68Ga-FAPI-46 PET scan for head and neck cancer staging
Part of Cancer clinical trials.
This trial tests a new type of PET scan that uses a special tracer (68Ga-FAPI-46) to see if it can better show the extent of head and neck cancers before surgery. It may help doctors plan your treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are generally healthy enough to do daily activities on your own (Karnofsky score 80% or higher)
- You have a confirmed head and neck cancer (squamous cell carcinoma) in the mouth, throat, or voice box
- The cancer has spread to at least one lymph node in your neck
- You are scheduled for surgery to remove lymph nodes from your neck (neck dissection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a new imaging agent called [18F]-AraG to see how well it can show head and neck cancers before and after standard radiation therapy. If you have advanced cancer of the throat or voice box that can't be surgically removed, this scan may help doctors understand your cancer better.
This trial uses a special PET scan to look at head and neck cancer cells before treatment. It may help doctors learn more about your cancer and decide if different treatments could work better for you.
This study uses a special type of PET scan called FAPI PET to see if it can help detect or monitor cancer and other diseases. It is for people who already need a PET or CT/MRI scan as part of their standard care.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This trial studies how well an imaging scan called 18F-FSPG PET shows whether head and neck or lung cancer responds to standard chemoradiotherapy. It may help doctors understand early signs of treatment success or failure.
Hear when a new Head and Neck Squamous Cell Carcinoma HNSCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.